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Multiplexed femtomolar quantitation of human
cytokines in a ﬂuoropolymer microcapillary ﬁlm†
Ana P. Castanheira,a Ana I. Barbosa,b Alexander D. Edwardsa,c and Nuno M. Reis*a,b
Sensitive quantitation of multiple cytokines can provide important diagnostic information during infection,
inﬂammation and immunopathology. In this study sensitive immunoassay detection of human cytokines
IL-1β, IL-6, IL-12p70 and TNFα is shown for singleplex and multiplex formats using a novel miniaturized
ELISA platform. The platform uses a disposable plastic multi-syringe aspirator (MSA) integrating 8 disposa-
ble ﬂuoropolymer microﬂuidic test strips, each containing an array of ten 200 μm mean i.d. microcapil-
laries coated with a set of monoclonal antibodies. Each MSA device thus performs 10 tests on 8 samples,
delivering 80 measurements. Unprecedented levels of sensitivity were obtained with the novel ﬂuoropoly-
mer microﬂuidic material and simple colorimetric detection in a ﬂatbed scanner. The limit of detection
for singleplex detection ranged from 2.0 to 15.0 pg ml−1, i.e. 35 and 713 femtomolar for singleplex cyto-
kine detection, and the intra- and inter-assay coeﬃcient of variation (CV) remained within 10%. In
addition, a triplex immunoassay was developed for measuring IL-1β, IL-12p70 and TNFα simultaneously
from a given sample in the pg ml−1 range. These assays permit high sensitivity measurement with rapid
<15 min assay or detection from undiluted blood serum. The portability, speed and low-cost of this
system are highly suited to point-of-care testing and ﬁeld diagnostics applications.
Introduction
Cytokines are important immune signaling proteins produced
following infection, tissue injury or during immunological
disease.1,2 Characteristic expression patterns have been identi-
fied both locally in tissues and in various clinical samples (e.g.
blood, serum, urine) that are associated with particular infec-
tions or immune and inflammatory diseases.1,3 Although cyto-
kine measurement is nowadays a routine task in research
laboratories, the ability to quantify rapidly multiple human
cytokines simultaneously, down to pg ml−1 range, in a disposa-
ble miniaturized platform has the potential of providing a
rapid identification and treatment of acute conditions such as
sepsis4,5 and accurate point-of-care (POC) discrimination6–10
between bacterial and viral infection based on few key cyto-
kines such as IL-6, TNFα, IL-10 combined with other bio-
markers like C reactive protein (CRP) and procalcitonin
(PCT).11
A major challenge to the routine measurement of cytokine
levels in conventional clinical samples (i.e. blood or urine) is
that cytokines are highly potent and typically exert their action
in a local tissue environment. For this reason, systemic levels
are normally very low, typically in the range of 1–10 pg ml−1 or
even lower, and highly elevated levels are usually only found in
clinical samples such as blood only either transiently or
during severe disease. Consequently, diagnostic tools must be
capable of accurately quantifying multiple biomarkers from
biological samples at very low concentrations. Although rapid
near-patient measurement is desirable, current methods for
sensitive quantitation of individual cytokines remain limited
to the laboratory setting.1 The gold standard technique for
cytokine quantitation is the enzyme-linked immunosorbant
assay (ELISA) performed in a microtiter plate (MTP) which can
meet the required high sensitivity and low assay variance,
using enzyme amplification to provide measureable signals.
This method typically measures only one cytokine per well
whilst requiring a skilled laboratory operator to perform and
analyse the test, and requires laboratory based detection
systems such as plate readers. MTP based sandwich immuno-
assays require long incubation times, multiple washing steps
and large reagent and sample volumes.12
To adapt the MTP format for measuring more than one
cytokine from each sample, a technique termed multiplexing,
fluorescence-based immunoassays platforms such as the
Luminex® system were developed. These systems are capable
†Electronic supplementary information (ESI) available: Supplementary experi-
mental design and supplementary results. See DOI: 10.1039/c5an00238a
aCapillary Film Technology Ltd, Billingshurst, West Sussex RH14 9SJ, UK
bDepartment of Chemical Engineering, Loughborough University, Leicestershire LE11
3TU, UK. E-mail: n.m.reis@lboro.ac.uk; Fax: +44 (0)1509 223 923;
Tel: +44 (0)1509 222 505
cReading School of Pharmacy, University of Reading, Reading RG6 6AD, UK.
E-mail: a.d.edwards@reading.ac.uk; Fax: +44 (0)118 931 4404;
Tel: +44 (0)118 378 4253
This journal is © The Royal Society of Chemistry 2015 Analyst, 2015, 140, 5609–5618 | 5609
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
8 
Ju
ne
 2
01
5.
 D
ow
nl
oa
de
d 
on
 1
0/
05
/2
01
6 
11
:3
6:
21
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
View Journal  | View Issue
of quantifying a set of cytokines using fluorescence detection
on antibody-coated polystyrene microspheres, reporting sensi-
tivities of 5.7 pg ml−1 for IL-6 and 5.2 pg ml−1 for IL-12.13 This
eﬀective laboratory method is particularly suited to high-
throughput biomarker screening and identification given the
capacity for very large numbers of simultaneous analytes (e.g.
20–40 per sample). Quinn et al.1 developed a related multi-
plexed cytokine assay utilizing VeraCode technology that uses
holographically encoded silica cylinders to perform fluo-
rescence immunoassays, and a two-laser scanning CCD imager
to identify individual beads and quantify fluorescence signal.
The sensitivity reported for all cytokines analyzed (IL-1b,
TNFα, IL-2, IL-5, IL-6, IL-12 and IL-10) was 0.5 pg ml−1, except
for IL-4 that presented a limit of detection of 14 pg ml−1.
However, both Luminex and VeraCode technologies require
long incubation times, complex fluid handling steps and
costly and complex software to analyze the fluorescence
signal.1 Consequently, these techniques have application
limited to the central diagnostic laboratory setting.
An alternative approach for multiplex quantitative cytokine
measurement is the use of microarrays. Wang et al.14 described
a chip capable of profiling human cytokine expression of
breast tumor cells and in cervical tumor samples, which was
fabricated by printing 43 cytokine and chemokine antibodies
into a microfluidic chip using a specialized polyacrylamide
formulation. The authors reported assay sensitivities below
20 pg ml−1 for five out of six cytokines studied. Although
capable of detecting a large set of cytokines, the assay protocol
remains complex requiring skilled personnel and currently
presents high manufacturing costs.
To overcome current limitations of laboratory diagnostic
systems, a range of microfluidic devices were recently deve-
loped and applied to the detection and quantitation of bio-
markers. Microfluidic technologies can reduce sample and
reagent volumes, whilst greatly shortening incubation times.
Many microfluidic assays can be measured using inexpensive
optoelectronic components developed for consumer elec-
tronics products such as smartphones. The major barrier to
market penetration of microfluidic immunoassays is the
current high fabrication cost and limited scale of manufacture
for microfluidic devices,15 which is combined with the
diﬃculty in achieving the high analytical sensitivity required
for measurement of cytokines in clinical samples (typically in
the range of picograms per milliliter in serum, in contrast to
nanograms to micrograms per milliliter for many other bio-
markers) without the use of more sophisticated signal detec-
tion equipment. A microfluidic study reported multiple
cytokine measurement in a miniaturized device with a biochip
array to analyze circulating human cytokines.3 Monoclonal
capture antibodies were bound in predefined positions on an
activated biochip surface, providing discrete test regions.3
Chemiluminescence was used to measure analyte, with a
reported sensitivity from 0.12 pg ml−1 for IL-6 to 2.12 pg ml−1
for IL-4, with twelve cytokines analysed in total. However, the
biochip still requires sophisticated automated fluid processing
and a dedicated benchtop reader, and remains laboratory based.
Colorimetric ELISA exploits simple, inexpensive and well
established enzyme assay chemistry with simpler detection
than fluorescent or chemiluminescent detection. For this
reason, colorimetric readouts are ideal for POC testing appli-
cations. Indeed, colorimetric detection in miniaturized
immunoassay formats has proved successful for detection of
biomarkers present at higher concentrations.16,17 However,
achieving suﬃcient sensitivity to measure analytes in the pg
ml−1 range using colorimetric readout has proved highly chal-
lenging in portable microfluidic systems. In this paper we
present a sensitive colorimetric sandwich assay with limits of
detection (LoDs) <2 pg ml−1 using conventional ELISA reagents
in miniaturized fluoropolymer multiplex test strips. This sensi-
tivity is comparable to that achieved with laboratory MTP
assays, and to fluorescence and chemiluminescence detection.
This article describes a new miniaturized platform for
rapid, sensitive and inexpensive quantitation of multiple
human cytokines based on a multiplexed fluoropolymer micro-
capillary film (MCF). The benefits of the new sandwich ELISA
platform are demonstrated by integrating 10-bore test strips
manufactured from a continuous melt-extruded MCF18
(Fig. S1b†) and operated with a portable, power free, 8-sample
Multi-Syringe Aspirator (MSA) device (Fig. S1a and S1c†)
capable of running up to 80 simultaneous ELISA tests.19 The
small internal diameter of the capillaries (206 ± 12.2 μm)
result in shortened diﬀusion distances and reduced volumes
of reagents required to run an assay, consequently the total
assay time is reduced by at least one order of magnitude when
compared to standard methods.18 The flat measurement sur-
faces of the MCF and low refractive index of fluoropolymer
material18 provides unique signal-to-noise ratios suitable for
measuring low concentrations of chromogenic substrates. This
is demonstrated by measuring a range of human cytokines,
IL-1β, IL-6, IL-12p70 and TNFα with a flatbed scanner using
commercial sandwich ELISA chemistry with total assay times
between 15 and 50 min.
Experimental section
Immunoassay reagents
All the following human cytokines reagents were purchased
from eBiosciences (Hatfield, UK): IL-1β (cat no: human recom-
binant protein #14-8018; Anti-Human IL-1β biotin #13-7016;
Anti-Human IL-1β purified #14-7018); IL-12p70 (cat no: human
recombinant protein #14-8129; Anti-Human IL-12p70 biotin
#13-7129; Anti-Human IL-12p70 purified #14-7128); IL-6 (cat
no: human recombinant protein #14-8069; Anti-Human IL-6
biotin #13-7068; Anti-Human IL-6 purified #14-7069); and
Tumor Necrosis Factor-α (TNFα) (cat no: human recombinant
protein #14-8329; Anti-Human TNFα biotin #13-7349; Anti-
Human TNFα purified #14-7348).
ExtrAvidin-Peroxidase (cat. no E2886), enzymatic substrate
SIGMAFASTTM OPD (o-phenylenediamine dihydrochloride)
tablets (cat. no P9187), Phosphate Buﬀered Solution (PBS, cat.
no P5368-10PAK), pH 7.4, 0.01 M, Tween 20 diluted in PBS
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0.05% v/v (PBS-T, P9416 – 50 ML) and Protease-free Albumin
from Bovine Serum (BSA, cat no. A3858) were sourced from
Sigma Aldrich Ltd (Dorset, SP8 4XT, UK). SuperBlock blocking
buﬀer in PBS (cat. no PN37515), High Sensitivity Streptavidin–
HRP (cat. no 21130) and High Sensitivity NeutrAvidin – HRP
(cat. no 31030) were supplied by Thermo Scientific (Northum-
berland, UK). 3,3′,5,5′ Tetramethylbenzidine (TMB, cat. no
DY999) was sourced from R&D Systems (Minneapolis, MN,
USA). Human serum (cat no. #CR200) was sourced from TCS
Biosciences (Buckingham, UK).
Fluoropolymer MCF
This consisted of a flat plastic ribbon containing 10 parallel
capillaries (Fig. S1b†) with mean internal diameter 206 ±
12.2 μm, manufactured by Lamina Dielectrics Ltd (Billing-
shurst, West Sussex, UK) by a continuous melt-extrusion
process from fluorinated ethylene propylene co-polymer (FEP-
Teflon®). The external dimensions of the MCF were 4.5 ±
0.10 mm wide and 0.6 ± 0.05 mm thick.
Sandwich ELISA protocol
Purified monoclonal anti-human antibodies (capAb) were
immobilized by passive adsorption on the internal walls of the
microcapillaries in 25–50 cm long strips of fluoropolymer
MCF, which takes advantage of the hydrophobic surface of
FEP microcapillaries. For singleplex cytokines detection,
capAb diluted in PBS buﬀer was aspirated through the set of
10 parallel microcapillaries using a 1 ml syringe connected to
the MCF with a 2 cm long silicone tube (ID 2 mm). For multi-
plex detection, each individual capillary was injected using a
30G × 12″ (0.3 mm × 13 mm) gauge needle until the whole
length of the capillary was visually filled with the solution. The
capAb solution was then incubated for 2 hours after which all
remaining binding sites were blocked with a suitable blocking
solution and incubated for another 1 hour. All immunoassay
steps were carried out at room temperature (20 °C). Sub-
sequently, the MCF strip was washed with PBS-T and trimmed
into a set of eight, 30 mm long test strips that were attached
using a push-fit seals onto a prototype 8-channel semi-disposa-
ble multi-syringe aspirator (MSA) (Fig. S1a†), as described in
Barbosa et al.19 Samples, wash buﬀer and reagents were
sequentially aspirated from the custom multi-well plate into
MCF test strips by turning the MSA control dial at the top of
the device anti-clockwise, which simultaneously moves a set of
8 plungers in the array of 1 ml disposable syringes held within
the MSA. All reagents and wash buﬀer could be pre-loaded on
the custom multi-well plate and then sequentially aspirated
with the device to complete the full sandwich assay, without
requiring any further fluid handling devices.
A 1 : 2 dilution series of human recombinant protein were
prepared in the custom multi-well plate (150 μl per sample),
and aspirated into the MCF test strips by turning the manual
knob 6×, which corresponds to approximately 78 μl of solution,
and incubated for 30 min. After washing with 150 μl of PBS-T,
150 μl of biotinylated anti-human cytokine antibody (detAb)
diluted in PBS was aspirated with the MSA, and incubated for
10 min and washed with further 150 μl of PBS-T. Subsequently,
high sensitivity streptavidin–HRP (HSS-HRP) conjugated
enzyme diluted in PBS was aspirated and incubated for 10 min
in the capillaries, followed by three washing steps with PBS-T.
The enzyme conjugated was selected based on the optimi-
zation study described in ESI.† Overall, for the range of biotin-
binding enzymes tested, avidin, streptavidin and neutravidin
each were reported by the manufacturer to bind four biotins
per molecule with high aﬃnity and selectivity.20 Finally, 150 μl
of enzymatic substrate consisting of OPD or TMB were aspi-
rated and the whole MSA device placed in a HP ScanJet G4050
Scanner and the MCF strips scanned at 2400 dpi resolution in
transmittance mode. The strips were scanned in intervals of
2–3 min over 30 minutes of incubation. The RGB images were
analysed using ImageJ software, from which the absorbance on
each individual capillary was determined from the grey scale
peak height in the split blue channel as described in previous
studies.18,19 Assay variability was determined based on sensi-
tivity, precision and recovery, following the method described
by Ederveen.21 Overall, CVs obtained for ELISA in the MCF
were well within those reported for the 96-well MTP, which is
in the range of 10–20%.21,22
Cytokine response curves
Unless otherwise stated, full response curves were built based
on the absorbance data for 2 min enzymatic substrate incu-
bation and fitted with a 4 Parameters Logistic (4PL) model
using solver tool in Microsoft Excel and performed using the
following conditions. Diﬀerent immunoassay formats were
tested in this study, (i) singleplex IL-1β, IL-12p70, IL-6 or TNFα
detection; (ii) duplex qualitative detection of IL-1β and IL-6,
and (iii) triplex quantitation of IL-1β, IL-12p70 and TNFα.
Immunoassays were performed based on the assay conditions
optimised for IL-1β as fully described in ESI,† for a concen-
tration of recombinant protein in the range of 1 ng ml−1–0 pg
ml−1 on a 1 : 2 dilution series for singleplex format or 1 : 3
dilution for triplex format. The standard concentration of capAb
used in the assays was 20 μg ml−1 for IL-1β, IL-12p70 and TNFα,
and 40 μg ml−1 for IL-6; 10 μg ml−1 for detAb; and 4 μg ml−1 for
HSS-HRP. Experimental details specific to the qualitative duplex
assay and quantitative triple assays are given in ESI.†
Results and discussion
Colorimetric microfluidic sandwich ELISA suited to simple
optoelectronic measurement was optimised to achieve sensi-
tive cytokine measurement and then assay performance evalu-
ated for a novel miniaturised fluoropolymer MCF platform that
exploits the unique properties of the fluoropolymer micro-
fluidic material in a portable manually operated multi-sample
device. Initially, singleplex assays were developed, where
10 replicate microcapillaries were used to measure a single
cytokine; subsequently duplex and triplex assays were develo-
ped where multiple cytokines were measured simultaneously
from each sample.
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Limit of quantitation of colorimetric signal with a flatbed scanner
Prior to optimising the cytokine sandwich ELISA protocol in
the fluoropolymer MCF, the optical detection of chromogenic
substrates was first studied. A series of dilutions of 2,3-di-
aminophenazine (DAP), the final product of OPD chromogenic
substrate after conversion by HRP, were scanned in fluoropoly-
mer MCF strips with a flatbed scanner, and in parallel peak
absorbance (450 nm) of the same dilutions was measured in a
96-well MTP using a microplate reader. The DAP absorbance
in the blue channel of the scanned image was calculated by
image analysis. The minimum concentration of DAP that
could be detected using the flatbed scanner was 62.5 µg ml−1,
which is about 250 times less sensitive than the minimum
concentration detectable in a MTP (0.244 µg ml−1, Fig. S5†).
This reduced sensitivity is likely to be linked to three com-
bined factors, all of which are shared with any colorimetric
microfluidic measurement technique used for signal quanti-
tation and based on optical imaging. Firstly, the 15-fold
reduction in light path distance within the 200 μm internal
diameter capillaries, compared to 100 μl in a microtiter plate
well (≈3 mm liquid path), reduces the absolute Abs values.
Secondly, the sensitivity is also limited by the broad wave-
lengths measured by the blue channel of the RGB sensor, in
contrast to the narrow band of wavelengths measured by a
dedicated UV-VIS plate reader that can be selected to closely
match the peak absorbance of enzyme substrate product.
Finally, the consumer imaging equipment may have intrinsi-
cally reduced sensitivity to low amounts of light absorbance
compared to a microtiter plate reader, which was engineered
specifically for sensitive absorbance readings. Such lack of
sensitivity has therefore to be overcome by increasing colori-
metric signal intensity and improving signal-to-noise ratio in
miniaturized ELISA system, which is not straightforward as indi-
cated from the lack of published reports of colorimetric ELISA
sensitivity below ng ml−1 in microfluidic devices, including
work in our research group with the same ELISA platform.19
Despite the relatively poor sensitivity of flatbed scanner in
respect to quantitation of colorimetric signal in microcapil-
laries, the dynamic range observed for DAP quantitation in the
fluoropolymer MCF was greater than that in the MTP reader,
exceeding 2 log10 units. This can be attributed to the very short
light path within the plastic microcapillaries, allowing quanti-
tative measurement of very high concentrations (around 2 mg
ml−1) of DAP expanding the concentration range for the
Lambert–Beer law. In contrast, a maximum concentration of
DAP in the range of 0.02 mg ml−1 was detected in the linear
range for the MTP (Fig. S5†). This suggested that in theory
limited sensitivity of optical reading could potentially be over-
come by speeding up enzymatic chromogenic signal amplifica-
tion in the MCF microcapillaries, yielding higher concentrations
of coloured DAP product for the same analyte concentration.
Optimisation of cytokine ELISA detection in microcapillaries
A number of parameters widely recognised to strongly aﬀect
sandwich ELISA signal and sensitivity were screened in the
fluoropolymer MCF strips in order to achieve high levels of
sensitivity. These included: capAb concentration and incu-
bation time; sample incubation time; detAb concentration;
enzyme conjugate type and concentration; substrate concen-
tration; type and incubation time of blocking solution; and
reagent diluent and the number and volume of wash steps.
Full details of optimisation study are described in the ESI† pro-
vided, and assay conditions summarised in Table S1 (ESI†).
Overall, reagent concentrations required for optimal ELISA
signal in MCF were significantly greater than those used for
MTP, typically 10 to 20 times higher. The small diameter of
the microcapillaries and format of the MSA device based on
sequential solution aspiration through microcapillaries per-
mitted, with the possibility of skipping some washing steps,
simplifying the overall sandwich ELISA protocol. This is linked
to the very short diﬀusion distances in the microcapillaries
which enable using an excess of reagents for replacing the
solutions in the microcapillaries; about 78 μl of reagents were
aspirated at each step through each 30 mm long MCF strip,
having internal volume of 10 μl, such that, in eﬀect, each
reagent was used as a washing solution. Nevertheless, it was
noticed that a washing step before adding the antigen is very
important to reduce the variability and improve signal
strength. As an example see Fig. S2 in ESI.†
The performance of the colorimetric ELISA in the fluoro-
polymer MCF was found to be extremely sensitive to concen-
tration of both capAb and detAb. A maximum signal-to-noise
ratio was obtained with 20 μg ml−1 of capAb (Fig. S4d†), which
is 10 to 20-fold higher than the concentration typically used
for coating plastic surface in MTPs. This is ultimately linked to
the larger surface-area-to-volume ratio of the 10-bore MCF
compared to a MTP; a 200 μm internal diameter capillary has
a surface-area-to-volume ratio about 16 times higher than a
96 well MTP with 100 μl of solution. It is worth noticing that a
9 mm long MCF strip has the same total surface area (i.e.
1.1 cm2) of a microwell in a 96 well MTP with 100 μl of solu-
tion. It can be shown that about 100 μg ml−1 of capAb is
required to achieve theoretical full surface coverage in a
200 μm internal diameter microcapillary. This suggests anti-
body orientation in FEP is favoured at capAb concentrations
lower than that required for full surface coverage, which agrees
with antibody adsorption studies in other plastic surfaces.23
Given that colourimetric measurements of converted sub-
strate with the flatbed scanner were far less sensitive than
microtiter plate, is it perhaps surprising that the full ELISA is
as sensitive as MTP. Again, this can be justified by the larger
surface-area-to-volume ratio of MCF, which is completely
coated with the capAb, yielding a higher surface monolayer
concentration in a circular microcapillary, which exceeds the
concentrations that can be obtained by immobilizing the
capAb in just a fraction of the inner surface of a microchannel,
or printing the capAb in spots within a microfluidic device.
The surface-area-to-volume ratio in a circular or elliptical
microcapillary entirely coated with capAb is 4 times larger
than the one obtained by coating just one surface in a micro-
channel with the same internal dimensions. The kinetics of
Paper Analyst
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antibody–antigen binding are favoured by the increased con-
centration of free binding sites of capAb on the microcapil-
laries surface, which results in higher assay sensitivity. The
binding of an immobilised capAb and recombinant protein
(Ag) can be represented by the simple equilibrium reaction:
capAbþ Ag$ capAb–Ag
According to Scatchard’s model24 the equilibrium can be
described by the expression:
B=F ¼ KaðN  BÞ ð1Þ
where B and F represent the concentrations (molarities) of the
bound and free ligand respectively, N is the total concentration
of the binding sites, Ka is the aﬃnity constant, and the term (N
– B) represents the concentration of the unoccupied (free)
binding sites on the binder molecule (i.e. immobilized capAb
molecule). For a given concentration of recombinant protein,
Ag, it can be shown that for a greater excess of immobilized
capAb in the MCF strips the concentration of unoccupied
binding sites also increases, which means the ratio B/F also
increases (i.e. B ≫ F), pushing the equilibrium towards the for-
mation of capAb–Ag complex at the surface of the capillaries
which is desirable for high-sensitivity immunoassays. This
step combined with high aﬃnity of the commercially available
cytokine antibodies (i.e. with high Ka) was crucial for detecting
pg ml−1 of human cytokines in this study.
Singleplex cytokine quantitation
Full response curves were performed with four diﬀerent
human cytokines, IL-1β, IL-12p70, IL-6 and TNFα using assay
conditions optimised for the IL-1β cytokine in the fluoropoly-
mer MCF strips. A 4PL model was fitted to the experimental
data based on minimum square diﬀerences and plotted as
continuous lines (Fig. 1a). Each cytokine presented a unique
response curve related to diﬀerences in antigen molecular
weight, aﬃnity and on/oﬀ binding rates for each antibody pair
that ideally would need to be optimised individually. Response
curves for all cytokines revealed a low background and higher
signal compared to the absorbance values typically expected
for MTP ELISA and those provided by the antibody supplier.
A LoD in the range of 2.0–15 pg ml−1 was obtained for all
cytokines measured for a total assay time of 50 min, plus
2 min of OPD conversion (Fig. 1c), in spite of the limited
detection sensitivity for colorimetric detection of converted
OPD substrate in microcapillaries in a flatbed scanner identi-
fied above. This corresponds to concentrations of between
3.5 × 10−14 to 7.1 × 10−13 molar. Recent work in our research
group, involving sandwich ELISA measurement of a cancer bio-
marker Prostate Specific Antigen (PSA, a 26 kDa MW protein)
in the same miniaturized ELISA platform,19 revealed a LoD
around 1 ng m−1 (i.e. about 38 picomolar), which is 2 to 3
orders of magnitude larger than the LoD found for cytokines.
This improvement in LoD is believed to be related to the
higher aﬃnity and quality of commercially available cytokine
reagents, which favours the formation of capAb–Ag and sub-
sequent Ag complexes on the surface of the plastic microcapil-
laries but also to the eﬀectiveness of antibody adsorption in
the FEP microcapillaries. Furthermore, the reported PSA assay
system was optimised for faster assay times, rather than high
sensitivity, since the clinically important range for PSA bio-
marker measurement is far higher than that of cytokines (i.e.
>1 ng ml−1 rather than ∼1–10 pg ml−1).
Measuring initial reaction rates can in theory give a better
measurement of enzyme concentration or immunoassay signal
Fig. 1 (a) Full response curves for singleplex cytokines sandwich ELISA
in ﬂuoropolymer MCF strips using the multi-syringe aspirator device and
HSS-HRP detection with a ﬂatbed scanner. Response curves for IL-1β,
IL-6, IL-12p70 and TNFα are represented after 2 min of OPD incubation.
(b) Initial rate of colour development of each cytokine, in a singleplex
assay. (c) Performance summary for each cytokine. Assay conditions as
described in the Experimental section.
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than endpoint measurement. By tracking the Abs development
in each individual strip, it was possible to plot the initial rate
against concentration for the whole set of cytokines measured.
The linear colour development for each cytokine observed at
early time points were used to measure initial velocity (Fig. 1b)
the (note only data points in the linear range were plotted).
However measuring initial rates did not result in improved
LoD over endpoint absorbance, possibly because of the low
scanning speed of the flatbed scanner, allowing just one scan
every 2 or 3 minutes, which is related to the minimum 2400 dpi
resolution required for image analysis. Rapid imaging using a
digital camera might allow more accurate determination of
initial rates and further improve assay performance.
Overall, IL-12 showed the lowest LoD among all cytokines
measured, followed by TNFα, IL-1β and IL-6, with LoDs in
molar basis of 35, 114, 426 and 713 femtomolar, respectively;
there LoDs were calculated based on the MW of 57 240 Da for
IL-12, 57 000 Da for TNFα, 17 380 Da for IL-1β and 21 041 Da
for IL-6 provided by the reagent manufacturers. The CV values
were all below 15% and the dynamic range for each cytokine
was at least 1.5 to 2.0 log units.
Assay variability
A detailed variability study was performed for singleplex IL-1β
detection as detailed in ESI.† From Fig. 1c the sensitivity of
the assay herein defined by the LoD was 7.4 pg ml−1 for cyto-
kine IL-1β. It is important to mention that LoD is referred to
the level above which samples were considered positives, but
this is not a very reliable measure of quantification; for that
purpose LoQ is of better use. Consequently, the linear range
obtained for IL-1β was 60 pg ml−1–250 pg ml−1, and from the
data a calibration curve could be fitted: Abs = 0.8153 × [IL-1β] +
0.04 (R2 = 0.9973).
The intra-assay precision was initially calculated across the
strips where diﬀerent capillaries in a given strip were com-
pared (for each concentration: sample = 6; n = 10). The % CV
was lower than 15% for all recombinant protein concen-
trations tested (LLoQ, MR and HLoQ) in all strips (Fig. 2a(i)).
Some variability from strip to strip was noticeable and
could be explained by small variation in the dimensions of the
microcapillaries, which is intrinsic to the continuous melt-
extrusion process used for manufacturing the MCF material
used in this study. Microscope images of the cross section of
the MCF taken 10 mm apart from the same batch (data not
shown) revealed a 5% variation on internal diameter of
the microcapillaries, which will improved in the future by
optimising the melt-extrusion process and utilising in-line
laser measurement to record film dimensions during pro-
duction. Alternatively, we have recently shown19 that assay
variability can be reduced in MCF by normalizing the absolute
Abs signal for each capillary by the light path distance,
which can be done by scanning a reference strip alongside the
assay strips.
The assay accuracy is directly related with % recovery and
consequently another parameter giving information about
reliability of the assay. In terms of % recovery (Fig. 2a(ii)), the
normal accepted range is between 80% and 120% that was in
general not met for MR concentration (150 pg ml−1) of recombi-
nant protein (% recovery higher than 150%), which might be
related to suboptimal washing. For both LLoQ and HLoQ the %
recovery was, in general, inside that range. The intra-assay pre-
cision between strips (for each concentration: sample = 1; n = 6),
which compares the mean values for each strip revealed % CV
lower than 10% for all concentrations tested (Fig. 2b(i)), though
the % recovery remained higher than 120% at the higher recom-
binant protein concentrations (Fig. 2b(ii)), that can possibly be
explained by the reasons previously highlighted. This data
shows that the assay is precise, but for some concentrations the
signal observed was sometimes higher than expected.
Each MCF strip contains 10 microcapillaries, allowing up to
10 replicate measurements for each small sample volume.
Assay variability was therefore compared for each capillary
position between diﬀerent strips. This is particularly relevant
for performance of duplex or multiplex assays in the fluoro-
polymer MCF strips. As expected, variability increased as the
concentration of analyte decreased, but CVs remained well
below 10% for all concentrations above LoQ, and close to the
LoQ CVs of up to 32% were observed (Fig. 2c).
In order to understand reproducibility of the assay in MCF
strips and MSA device, the Inter-assay precision was also
studied. It was observed variability lower than 15% for MR con-
centration and lower than 10% for the LLoQ and HLoQ. The
higher % recovery was obtained at the LLoQ which was 133%,
followed by MR with an average % recovery of 123% (Fig. 2d).
The Intra-assay analysis is mainly aﬀected by internal variables
such as fluid handling, washing steps and variation on the
internal diameter of the capillaries, whereas the inter-assay is
mainly depend on external variables such as operator, environ-
ment, device, etc., meaning that the assay internal variables
are more critical in terms of accuracy of the method.
Quantitative triplex measurements
To demonstrate the multiplex capability of this platform,
quantitative detection of three cytokines was performed (IL-1β,
IL-12 and TNFα) in each fluoropolymer MCF strip using assay
conditions optimised for singleplex IL-1β cytokine. This ulti-
mately demonstrates the ability of this new miniaturized
platform to perform portable and sensitive multiplex immuno-
assay measurements in a very cost eﬀective manner.
An important observation from Fig. 3 is that capillaries
coated with 3% BSA showed Abs values close to 0.05, higher
than the Abs values observed in the capillaries that were not
coated with a capAb or protein (Fig. 3a). Note that all micro-
capilaries were subsequently coated with Superblock. This
could be explained either by BSA coating interacting with one
or more detAb to produce background, or less eﬃcient block-
ing with BSA followed by Superblock. This highlights the
importance of selecting a good blocking agent to achieve sub
nanogram/milliliter detection.
The full response curves for each cytokine measured in the
multiplex strips were plotted by averaging Abs in the two capil-
laries coated with the same capAb on a given strip (Fig. 3b).
Paper Analyst
5614 | Analyst, 2015, 140, 5609–5618 This journal is © The Royal Society of Chemistry 2015
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
8 
Ju
ne
 2
01
5.
 D
ow
nl
oa
de
d 
on
 1
0/
05
/2
01
6 
11
:3
6:
21
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
The best-fitting of the 4PL model to the experimental data
returned a cross-correlation coeﬃcient, R2 = 0.998 for IL-1β,
0.996 for IL-12 and 0.998 for TNFα. Compared to the singleplex
cytokines detection, the response curves showed similar
profile in terms of absolute Abs values but also a small
increase in the background. That was believed to be linked to
the great excess of biotinylated detection antibodies resulting
from mixing all diﬀerent detAb. Consequently, the multiplex
assay was further optimised in respect of detAb and HRP con-
centration in order to reduce this raised background and thus
improve the multiplex assay to the same LoDs and LoQs
reported by singleplex detection. The best combination was
found to be 5 µg ml−1 of detAb and 2 µg ml−1 of Enzyme and,
although the signal intensity dropped, it resulted in a clear
improvement to the signal-to-noise ratio (Fig. S7†). In this
instance, the Abs values for the control strips were determined
from the average of three runs using the same conditions.
The full response curves and LoDs and LoQs values of the
assay using the optimised conditions were then finally deter-
mined with a significant improvement on the LoDs and LoQs
(Fig. 4) compared to previous conditions in Fig. 3. In addition
to the conventional end-point Abs measurement, it was poss-
ible to read Abs values in MCF real-time and therefore plot
response curves based on velocity data, as shown in Fig. 4b,
with clear benefits in respect to LoD and LoQ for IL-1β and
TNFα cytokines. In addition to the eventual problems of cross-
reactivity for multi-analyte detection (that were not detectable
in this study), it is important to consider the eﬀect of cumulat-
ive increase in total biotinylated detection antibody concen-
tration when developing a specific multiplex test panel.
Fig. 2 Variability study. (a) Shows the % CV and % recovery values of the assay across the strips, where diﬀerent capillaries on the same strip are
compared (for each concentration: sample = 6; n = 10). (b) Presents the % CV and % recovery values of the assay between strips (for each concen-
tration: sample = 1; n = 6), which compares the mean values for each strip. (c) Shows the % CV values of the assay when same capillary is analysed
and compared in diﬀerent strips. The % CV values were revealed between 5% and 14% in (a) and (b) and between 3% and 33% in (c). 60%–160% is
the range observed for the Recovery values. (d) Inter-assay precision: (i) CV values that are between 3% and 10% and (ii) % recovery values between
110% and 130%. The study was performed as described in supplementary experimental design section provided in ESI,† and used cytokine IL-1β as
recombinant protein. All values are represented in percentage (%) basis.
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Rapid cytokine detection
The robust and consistent cytokine measurements in the
fluoropolymer MCF strips after optimization for analytical sen-
sitivity allowed further assay time reductions. A rapid, 17 min
IL-6 assay was performed using 40 μg ml−1 of capAb concen-
tration by reducing the times of incubation of sample, detAb
and HSS-HRP to only 5 minutes, plus 2 minutes for substrate
conversion. It was noticed that not only that the signal was not
significantly aﬀected but also the LoD was slightly improved to
31 pg ml−1 when the rapid assay was performed (Fig. 5a). The
high concentration of capAb immobilized on the surface of
the fluoropolymer MCF strips appears to be a major factor for
rapid assays by favouring the rapid binding of Ag molecules to
the capAb without increasing the non-specific (background)
signal. On the other hand, the enzyme concentration was
Fig. 3 Triplex measurement of IL-1β, IL-12p70 and TNFα. (a) Capillaries
1 and 10 were coated with PBS; capillaries 2 and 8 coated with BSA 3%;
the capillaries 3 and 4, 5 and 6 and 7 and 8 coated with anti-human
IL-1β puriﬁed, anti-human IL-12 puriﬁed and anti-human TNFα puriﬁed,
respectively. The assay was performed using 1 : 3 serial dilution starting
from the stocking solution with 5 ng ml−1 of concentration as described
in ESI.† (b) Cytokines full response curves for multiplex sandwich ELISA
in MCF platform using the multi-syringe device and HSS-HRP detection
using a ﬂatbed scanner. Cytokines IL-1β, IL-12p70 and TNFα are rep-
resented for 2 min of OPD incubation.
Fig. 4 Optimised triplex measurement of IL-1β, IL-12p70 and TNFα (a)
full response curve of each cytokine using the optimised conditions as
described in the text. (b) Initial velocities of colour development of each
cytokine in a triplex assay. (c) Typical performance of each cytokine
using the optimised concentrations of detAb and Enzyme on the same
conditions as the triplex assays shown in Fig. 3.
Paper Analyst
5616 | Analyst, 2015, 140, 5609–5618 This journal is © The Royal Society of Chemistry 2015
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
8 
Ju
ne
 2
01
5.
 D
ow
nl
oa
de
d 
on
 1
0/
05
/2
01
6 
11
:3
6:
21
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
decreased to 1 μg ml−1 in order to balance the high capAb con-
centration and keep the background values low.
Assay performance in undiluted human serum
Additional experiments demonstrated that MCF cytokine
detection is also possible in undiluted human serum. Using a
total assay time of 30 min and a concentration of capAb of
40 μg ml−1, the LoD obtained for IL-1β was 14 pg ml−1
(Fig. 5b), which compares well to the assay optimised in buﬀer
based on 50 min total assay time (Fig. 1). Compared to full
response curve in buﬀer (data not shown), the signal dropped
by 18% for the same total assay time. We believe this is linked
to higher viscosity of the matrix, which will be subject of
future studies, and can be controlled by comparing measure-
ments in human serum samples to a reference curve in a
diluent that closely replicates human serum giving more
appropriate reference values.
Conclusions
A rapid, low cost, sensitive and precise microfluidic platform
for multiple cytokine detection and quantitation was deve-
loped based on a miniaturized fluoropolymer MCF. The full
response curves for singleplex detection of IL-1β, IL-12, IL-6
and TNFα confirmed an unprecedented LoD between
2.0–15.0 pg ml−1 for the whole set of cytokines tested, and CV
values lower than 10% using colorimetric enzymatic amplifica-
tion and detection using a flatbed scanner. The qualitative
duplex and quantitative triplex assays provided evidence that
the miniaturized MCF platform can eﬃciently measure mul-
tiple cytokines and deliver LoDs in the range of 60–150 pg
ml−1 with CVs lower than 10%. The short diﬀusion distances
in the microcapillaries oﬀers also the possibility of performing
full sandwich assay for cytokine measurement in less than
20 minutes or from undiluted human serum. The simple and
inexpensive optical detection system combined with the capa-
bility of delivering 80 data points simultaneously on the same
MSA device and cutting total assay time of sandwich ELISAs
shows unique advantages suited to POC testing, with the
possibility of being operated by a trained lab technician or an
unskilled person on the field. Further work is focussed on
further improving the analytical sensitivity and accuracy of
multiplex assays, on measurements in clinical samples, and
on automation of this manually operated device. The results
presented for cytokine measurements are believed to be rele-
vant for the development of a new generation of portable and
inexpensive miniaturized diagnostics tools for early and accu-
rate diagnostic of acute conditions such as sepsis, and assist
clinicians on the POC detection of bacterial infections, redu-
cing overuse of antibiotics.
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